Abstract
Background Extraintestinal manifestations of inflammatory bowel disease (IBD) frequently involve the skin and eyes. Although current management guidelines emphasize multidisciplinary surveillance, referral practices to dermatology and ophthalmology remain inconsistent across specialties, potentially affecting disease control and patient outcomes. Methods A retrospective chart review was conducted at the George Washington University Hospital, an urban tertiary academic medical center in Washington, D.C., USA, between August 2023 and August 2025. Adult patients (≥18 years) with Crohn's disease, ulcerative colitis, or indeterminate colitis seen in the gastroenterology clinic were identified. Patients with active referrals to dermatology or ophthalmology were included, while those without documented referrals or with incomplete medical records were excluded. Referral patterns, adherence to specialty appointments, and remission status were analyzed. A total of 102 dermatology and ophthalmology referrals among 586 patients with IBD were evaluated. Results Adherence to both dermatology and ophthalmology referrals was significantly associated with disease remission (p < 0.05). Dermatology referrals demonstrated higher adherence rates and were more frequently preventive in nature, whereas ophthalmology referrals were more commonly initiated in response to active symptoms and disease complications. Conclusions Preventive dermatologic surveillance in patients with IBD is associated with improved adherence and favorable disease outcomes. This proactive model may inform the development of standardized referral frameworks across IBD-related specialties, particularly ophthalmology, to strengthen multidisciplinary care and optimize long-term patient outcomes.